These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 21600982)

  • 1. Anti-thyroid cancer properties of a novel isoflavone derivative, 7-(O)-carboxymethyl daidzein conjugated to N-t-Boc-hexylenediamine in vitro and in vivo.
    Somjen D; Grafi-Cohen M; Katzburg S; Weisinger G; Izkhakov E; Nevo N; Sharon O; Kraiem Z; Kohen F; Stern N
    J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):95-103. PubMed ID: 21600982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of human thyroid carcinoma and goiter cells in vitro by the isoflavone derivative 7-(O)-carboxymethyl daidzein conjugated to N-t-boc-hexylenediamine.
    Somjen D; Grafi-Cohen M; Weisinger G; Izkhakov E; Sharon O; Kraiem Z; Fliss D; Zikk D; Kohen F; Stern N
    Thyroid; 2012 Aug; 22(8):809-13. PubMed ID: 22799572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-proliferative effects of a novel isoflavone derivative in medullary thyroid carcinoma: an in vitro study.
    Greenman Y; Grafi-Cohen M; Sharon O; Knoll E; Kohen F; Stern N; Somjen D
    J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):256-61. PubMed ID: 22776298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sorafenib-sparing effect in the treatment of thyroid carcinoma cells attained by co-treatment with a novel isoflavone derivative and 1,25 dihydroxyvitamin D3.
    Izkhakov E; Sharon O; Knoll E; Aizic A; Fliss DM; Kohen F; Stern N; Somjen D
    J Steroid Biochem Mol Biol; 2018 Sep; 182():81-86. PubMed ID: 29702263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo.
    Antonelli A; Bocci G; La Motta C; Ferrari SM; Fallahi P; Ruffilli I; Di Domenicantonio A; Fioravanti A; Sartini S; Minuto M; Piaggi S; Corti A; Alì G; Di Desidero T; Berti P; Fontanini G; Danesi R; Da Settimo F; Miccoli P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E528-36. PubMed ID: 22278419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of the antiproliferative activities of derivatives of carboxyalkyl isoflavones linked to N-t-Boc-hexylenediamine.
    Kohen F; Gayer B; Kulik T; Frydman V; Nevo N; Katzburg S; Limor R; Sharon O; Stern N; Somjen D
    J Med Chem; 2007 Dec; 50(25):6405-10. PubMed ID: 17990847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
    Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
    Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and microarray analysis of rexinoid-responsive anaplastic thyroid carcinoma.
    Klopper JP; Berenz A; Hays WR; Sharma V; Pugazhenthi U; Janssen J; Singh M; Bissonnette RP; Haugen BR
    Clin Cancer Res; 2008 Jan; 14(2):589-96. PubMed ID: 18223235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
    Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
    Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen inhibits growth, migration, and invasion of human follicular and papillary thyroid cancer cells in vitro and in vivo.
    Hoelting T; Siperstein AE; Duh QY; Clark OH
    J Clin Endocrinol Metab; 1995 Jan; 80(1):308-13. PubMed ID: 7829632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells.
    Xu J; Moatamed F; Caldwell JS; Walker JR; Kraiem Z; Taki K; Brent GA; Hershman JM
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4990-6. PubMed ID: 14557485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibitory effects of flavonoids in human thyroid cancer cell lines.
    Yin F; Giuliano AE; Van Herle AJ
    Thyroid; 1999 Apr; 9(4):369-76. PubMed ID: 10319943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo.
    Luong QT; O'Kelly J; Braunstein GD; Hershman JM; Koeffler HP
    Clin Cancer Res; 2006 Sep; 12(18):5570-7. PubMed ID: 17000694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines.
    Ain KB; Taylor KD; Tofiq S; Venkataraman G
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1857-62. PubMed ID: 9177396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D less-calcemic analog modulates the expression of estrogen receptors, vitamin D receptor and 1α-hydroxylase 25-hydroxy vitamin D in human thyroid cancer cell lines.
    Somjen D; Grafi-Cohen M; Posner GH; Sharon O; Kraiem Z; Stern N
    J Steroid Biochem Mol Biol; 2013 Jul; 136():80-2. PubMed ID: 23059472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas.
    Zeng Q; Chen G; Vlantis A; Tse G; van Hasselt C
    J Pathol; 2008 Mar; 214(4):425-33. PubMed ID: 18085520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
    Altmann A; Markert A; Askoxylakis V; Schöning T; Jesenofsky R; Eisenhut M; Haberkorn U
    J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action.
    Banu KS; Govindarajulu P; Aruldhas MM
    Endocr Pathol; 2001; 12(3):315-27. PubMed ID: 11740053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tyrosine kinase inhibitor, AZD2171, inhibits vascular endothelial growth factor receptor signaling and growth of anaplastic thyroid cancer in an orthotopic nude mouse model.
    Gomez-Rivera F; Santillan-Gomez AA; Younes MN; Kim S; Fooshee D; Zhao M; Jasser SA; Myers JN
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4519-27. PubMed ID: 17671138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.